GlassScriptPhysician profile
Amy M Bower
NPI 1881913887
$1,314.24
in general payments reported to CMS, 2019-2025
11 companies · $162 in 2025
The $162 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $168 · 2022: $449 · 2023: $322 · 2024: $214 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $697.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $264.17 | 2021-2024 | Gore Synecor Biomaterial, Gore Bio-A Tissue Reinforcement |
| Davol INC. | $221.11 | 2022-2023 | Phasix Mesh |
| Organon LLC | $199.69 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $174.58 | 2024-2025 | |
| Ethicon US, LLC | $146.62 | 2022-2025 | Mega Soft, Dermabond |
| Intuitive Surgical, INC. | $114.11 | 2021 | |
| Tela Bio, INC. | $93.93 | 2024 | Ovitex 2s |
| Stryker Corporation | $54.80 | 2023 | Stryker |
| Astrazeneca Pharmaceuticals LP | $16.34 | 2025 | Lokelma |
| Pacira Pharmaceuticals Incorporated | $16.03 | 2021 | |
| Merck Sharp & Dohme LLC | $12.86 | 2023 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Bower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.